Report

Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase η

Science  09 Nov 2007:
Vol. 318, Issue 5852, pp. 967-970
DOI: 10.1126/science.1148242

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

DNA polymerase η (Pol η) is a eukaryotic lesion bypass polymerase that helps organisms to survive exposure to ultraviolet (UV) radiation, and tumor cells to gain resistance against cisplatin-based chemotherapy. It allows cells to replicate across cross-link lesions such as 1,2-d(GpG) cisplatin adducts (Pt-GG) and UV-induced cissyn thymine dimers. We present structural and biochemical analysis of how Pol η copies Pt-GG–containing DNA. The damaged DNA is bound in an open DNA binding rim. Nucleotidyl transfer requires the DNA to rotate into an active conformation, driven by hydrogen bonding of the templating base to the dNTP. For the 3′dG of the Pt-GG, this step is accomplished by a Watson-Crick base pair to dCTP and is biochemically efficient and accurate. In contrast, bypass of the 5′dG of the Pt-GG is less efficient and promiscuous for dCTP and dATP as a result of the presence of the rigid Pt cross-link. Our analysis reveals the set of structural features that enable Pol η to replicate across strongly distorting DNA lesions.

    View Full Text

    Related Content